KALEXATE Drug Patent Profile
✉ Email this page to a colleague
When do Kalexate patents expire, and what generic alternatives are available?
Kalexate is a drug marketed by Kvk Tech and is included in one NDA.
The generic ingredient in KALEXATE is sodium polystyrene sulfonate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Kalexate
A generic version of KALEXATE was approved as sodium polystyrene sulfonate by CMP PHARMA INC on January 19th, 1989.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for KALEXATE?
- What are the global sales for KALEXATE?
- What is Average Wholesale Price for KALEXATE?
Summary for KALEXATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| DailyMed Link: | KALEXATE at DailyMed |
US Patents and Regulatory Information for KALEXATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kvk Tech | KALEXATE | sodium polystyrene sulfonate | POWDER;ORAL, RECTAL | 040905-002 | Apr 3, 2015 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Kvk Tech | KALEXATE | sodium polystyrene sulfonate | POWDER;ORAL, RECTAL | 040905-001 | Mar 30, 2009 | AA | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
